Kyiv, Ukraine and Salt Lake City, UT, April 09, 2025 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, today announced ...

Recursion (NASDAQ: RXRX) began Wednesday down in its stock price. The company purporting to be a leading clinical stage TechBio company decoding biology to radically improve lives, today announced the ...

Recursion Pharmaceuticals. has filed a patent for a computer system that identifies a subset of compounds through high throughput screening in various cell contexts. The system obtains vectors for ...

Recursion announced its partnership with Enamine, a world-renowned provider of novel molecules and contract research services, to generate enriched screening libraries with insights from Recursion’s ...

For the first time ever, a demonstration version of one of Recursion's Compound Intelligence tools to explore maps of biology and chemistry is open for anyone to use RxRx3, the underlying dataset ...